Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

MEASUREMENT METHODS - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (https://rgd.mcw.edu/rgdweb/contact/contactus.html).
Term:liquid phase colorimetry
go back to main search page
Accession:MMO:0000329 term browser browse the term
Definition:A technique by which the color of a sample following a reaction carried out in solution, that is, in a substance composed of molecules that can move about relatively freely and which exhibits a characteristic readiness to flow, little or no tendency to disperse, and relatively high incompressibility, is evaluated in terms of standard colors.


show annotations for term's descendants           Sort by:
liquid phase colorimetry term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Gluco65 Glucose level QTL 65 IDA RGD PMID:25003539 RGD:8694157 NCBI chr 9:496,645...45,496,645 JBrowse link
Q Gluco66 Glucose level QTL 66 IDA RGD PMID:25003539 RGD:8694157 NCBI chr13:17,711,336...62,711,336 JBrowse link
Q Gluco67 Glucose level QTL 67 IDA RGD PMID:25003539 RGD:8694157 NCBI chr14:1...40,068,101 JBrowse link
Q Gluco68 Glucose level QTL 68 IDA RGD PMID:25003539 RGD:8694157 NCBI chr18:31,990,891...76,990,891 JBrowse link
Q Insul19 Insulin level QTL 19 IDA RGD PMID:22947656 RGD:6893578 NCBI chr 1:197,489,281...200,611,765 JBrowse link
Q Rf51 Renal function QTL 51 IDA RGD PMID:10545438 RGD:619628 NCBI chr 1:228,180,370...266,453,608 JBrowse link
Q Scl45 Serum cholesterol level QTL 45 IDA RGD PMID:16061941 RGD:1547851 NCBI chr14:65,920,283...99,224,555 JBrowse link
Q Scl59 Serum cholesterol level QTL 59 IDA RGD PMID:18753676 RGD:2300117 NCBI chr14:55,147,478...100,147,478 JBrowse link
Q Sffal1 Serum free fatty acids level QTL 1 IDA RGD PMID:15728334 RGD:1580752 NCBI chr 7:118,556,868...125,929,417 JBrowse link
Q Sffal2 Serum free fatty acids level QTL 2 IDA RGD PMID:15728334 RGD:1580752 NCBI chr14:96,755,448...100,078,267 JBrowse link
Q Sffal3 Serum free fatty acids level QTL 3 IDA RGD PMID:25003539 RGD:8694157 NCBI chr 2:28,889,991...73,889,991 JBrowse link
Q Sffal4 Serum free fatty acids level QTL 4 IDA RGD PMID:25003539 RGD:8694157 NCBI chr 4:1...32,668,025 JBrowse link
Q Sffal5 Serum free fatty acids level QTL 5 IDA RGD PMID:25003539 RGD:8694157 NCBI chr 7:7,216,097...52,216,097 JBrowse link
Q Sffal6 Serum free fatty acids level QTL 6 IDA RGD PMID:25003539 RGD:8694157
Q Sffal7 Serum free fatty acids level QTL 7 IDA RGD PMID:25003539 RGD:8694157 NCBI chr17:33,104,645...78,104,645 JBrowse link
Q Sffal8 Serum free fatty acids level QTL 8 IDA RGD PMID:25003539 RGD:8694157 NCBI chr20:1...29,193,376 JBrowse link
Q Stl10 Serum triglyceride level QTL 10 IDA RGD PMID:14724732 RGD:737686 NCBI chr 4:22,288,453...45,429,897 JBrowse link
Q Stl11 Serum triglyceride level QTL 11 IDA RGD PMID:14724732 RGD:737686 NCBI chr 7:121,393,075...137,014,596 JBrowse link
Q Stl12 Serum triglyceride level QTL 12 IDA RGD PMID:14724732 RGD:737686
Q Stl20 Serum triglyceride level QTL 20 IDA RGD PMID:15728334 RGD:1580752
Q Stl21 Serum triglyceride level QTL 21 IDA RGD PMID:15728334 RGD:1580752 NCBI chr15:43,677,244...88,677,244 JBrowse link
Q Uminl1 Urine mineral level QTL 1 IDA RGD PMID:25003539 RGD:8694157 NCBI chr 3:48,657,744...93,657,744 JBrowse link
Q Uminl2 Urine mineral level QTL 2 IDA RGD PMID:25003539 RGD:8694157 NCBI chr 6:44,510,974...89,510,974 JBrowse link
Q Uminl3 Urine mineral level QTL 3 IDA RGD PMID:25003539 RGD:8694157 NCBI chr 8:80,768,445...125,768,445 JBrowse link
Q Uminl4 Urine mineral level QTL 4 IDA RGD PMID:25003539 RGD:8694157 NCBI chr14:59,848,686...104,848,686 JBrowse link
Q Uminl5 Urine mineral level QTL 5 IDA RGD PMID:25003539 RGD:8694157 NCBI chr19:7,997,750...52,997,750 JBrowse link
bromocresol green-based urine albumin analysis with spectrophotometric readout term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Rf3 Renal disease susceptibility QTL 3 IDA RGD PMID:11053483 RGD:70856
Lowry protein assay term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Aocep1 Aortic cell protein QTL 1 IDA RGD PMID:15668357 RGD:1334448
peptide/protein analysis by liquid phase colorimetry term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Rf2 Renal disease susceptibility QTL 2 IDA RGD PMID:8528250 RGD:61060 NCBI chr 1:142,582,180...153,680,016 JBrowse link
protein analysis by liquid phase colorimetry with spectrophotometric readout term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Pur1 Proteinuria QTL 1 IDA RGD PMID:9799838 RGD:619599 NCBI chr13:37,087,983...39,968,353 JBrowse link
Q Pur12 Proteinuria QTL 12 IDA RGD PMID:16390874 RGD:1578625 NCBI chr 2:114,032,149...150,226,270 JBrowse link
Q Pur13 Proteinuria QTL 13 IDA RGD PMID:16390874 RGD:1578625 NCBI chr 3:98,651,826...167,012,663 JBrowse link
Q Pur14 Proteinuria QTL 14 IDA RGD PMID:16390874 RGD:1578625 NCBI chr17:7,985,243...16,523,460 JBrowse link
Q Pur15 Proteinuria QTL 15 IDA RGD PMID:16390874 RGD:1578625 NCBI chr20:8,043,920...15,089,182 JBrowse link
Q Pur16 Proteinuria QTL 16 IDA RGD PMID:18064521 RGD:2292230
Q Pur3 Proteinuria QTL 3 IDA RGD PMID:14638907 RGD:730279

Related Phenotype Data for Term "liquid phase colorimetry" (MMO:0000329)

Rat Strains:
Clinical Measurements:
Experimental Conditions:
Measurement Methods:
Term paths to the root
Path 1
Term Annotations click to browse term
  measurement method 2368
    ex vivo method 1236
      spectrometry 56
        photometry 40
          colorimetry 40
            liquid phase colorimetry 36
              creatinine analysis by liquid phase colorimetry + 0
              inulin analysis by liquid phase colorimetry + 0
              lipid peroxide analysis by liquid phase colorimetry + 0
              microplate reader 0
              nitrite analysis by liquid phase colorimetry + 0
              p-aminohippurate analysis by liquid phase colorimetry 0
              peptide/protein analysis by liquid phase colorimetry + 10
paths to the root